In clinical research settings around the world, renewed investigations are taking place on
the use of psychedelic substances for treating illnesses such as addiction, depression …

Psychedelics have shown great promise in modern clinical trials for treating various
psychiatric conditions. As a transdiagnostic treatment that exerts its effects through …

The purpose of this commentary is to provide an introduction to this special issue of
Neuropharmacology with a historical perspective of psychedelic drug research, their use in …

The medical use of psychedelic substances (eg psilocybin, ayahuasca, lysergic acid
diethylamide and 3, 4-methylenedioxymethamphetamine) is attracting renewed interest …

With the extensive public, commercial and scientific interest from what has been widely
termed the psychedelic renaissance, it is important that the scientific practices and results …

Psychedelic drugs are making waves as modern trials support their therapeutic potential
and various media continue to pique public interest. In this opinion piece, we draw attention …

Psychedelic therapy is perhaps the most exciting new development in psychiatry. Not only
does it offer a radical new approach to treatment where mainstream approaches have …

Research in the last decade has expressed considerable optimism about the clinical
potential of psychedelics for the treatment of mental disorders. This optimism is reflected in …

The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and
mescaline, were used extensively in psychiatry before they were placed in Schedule I of the …

Psychedelic therapy: a roadmap for wider acceptance and utilization | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …